Fusion

4 results

Belfast research contract group Fusion Antibodies reported record second-half revenues as it moves past AIM-listing pressures.

Northern Ireland contract research company Fusion Antibodies recorded a 19 per cent fall in full year revenues to £2.2 million on the back of a weak f(...)

Paul Kerr, chief executive of Fusion Antibodies.

Northern Ireland contract research company Fusion Antibodies warned that revenues for the year ended March 31st would be “materially below current mar(...)

Fusion Antibodies said the outlook for the next trading year is a positive one. Photograph: iStock

Belfast pharmaceutical company Fusion Antibodies said it expects revenues for the trading year ended March 31st 2018 to grow at least 40 per cent on t(...)

It’s here at last but can the new Mondeo turn around Ford’s European saloon woes?

Ford has just launched a new car that is already two years old, as it has finally announced prices, specifications and, finally, an on-sale date for t(...)